Harley Robinson
Dr Harley Robinson is an early-career postdoctoral researcher in the Cardiac Drug Discovery Laboratory at QIMR Berghofer (Brisbane). After completing a PhD with A/Prof Michelle Hill on the mechanisms underlying advanced prostate cancer (2017–2022), and contributing to COVID-19 research in 2021, she transitioned to heart failure research in mid-2022 under Prof James Hudson (Cardiac Bioengineering Lab, QIMRB). Her current work integrates human cardiac organoids and human heart tissue with proteomic, phosphoproteomic, and interactomic investigations into cardiac physiology and pathology. Areas of focus include sepsis, fibrosis, tissue regeneration, and inflammation-driven dysfunction.
Abstracts this author is presenting:
